The chemical class described as KIAA0391 inhibitors encompasses a spectrum of molecules designed to modulate the activity of KIAA0391, a protein implicated in RNA-related cellular processes. These inhibitors do not directly target KIAA0391 but rather exert their effects on the pathways and mechanisms in which KIAA0391 is a participant. Given that KIAA0391 is thought to play a role in RNA regulation, the inhibitors could influence various stages of RNA metabolism, including synthesis, splicing, modification, and degradation. By interfering with these processes, the inhibitors can alter the functional output of KIAA0391, leading to a downstream impact on gene expression regulation and cellular homeostasis.
Inhibitors in this class can operate through multiple mechanisms. Some may act by competitively binding to the active or allosteric sites of key enzymes in the RNA processing pathways, thus preventing those enzymes from interacting with their natural substrates or cofactors. This mode of action can lead to a cascade of effects due to the interconnected nature of metabolic pathways, where the inhibition of one step can influence several downstream processes. Other inhibitors may bind to regulatory proteins that modulate the activity of KIAA0391, thereby indirectly affecting its function. Additionally, certain inhibitors might mimic structural elements of RNA or protein partners of KIAA0391, leading to the disruption of critical protein-RNA or protein-protein interactions necessary for the proper function of RNA metabolic pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with DNA-dependent RNA polymerase by preventing RNA synthesis. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, affecting mRNA synthesis and processing. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II transcriptional elongation. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Alters RNA polymerase II-mediated transcription and may impact RNA processing. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Inhibits RNA polyadenylation by terminating RNA chain elongation. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibits nuclear export of RNA, affecting RNA processing and metabolism. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Inhibits cyclin-dependent kinases (CDKs) that may regulate transcription and RNA processing. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
A CDK inhibitor, possibly impacting transcription and RNA processing. | ||||||
BMH-21 | 896705-16-1 | sc-507460 | 10 mg | $165.00 | ||
Binds to RNA polymerase I and inhibits ribosomal RNA synthesis. | ||||||
1-β-D-Arabinofuranosylcytosine | 147-94-4 | sc-201628 sc-201628A sc-201628B sc-201628C sc-201628D | 1 g 5 g 25 g 100 g 250 g | $150.00 $263.00 $518.00 $731.00 $1461.00 | 1 | |
Inhibits DNA polymerase, affecting RNA synthesis indirectly. | ||||||